COT, cross-over trial; RCT, randomized controlled trial.

To date, six other meta-analyses of prokinetic agents for treatment of FD have been reported ( Table 2). [43,44,45,46,47,48] In terms of the agents investigated and the scope of the literature ...

The team at Nankai’s College of Pharmacy designed and developed a prokinetic agent CP0119, which can stimulate peristalsis — the symmetric contraction and relaxation of gut muscles.